Orange Heart Optimal Technology
Total Raised
$4.1BInvestors Count
2Funding, Valuation & Revenue
4 Fundings
Orange Heart Optimal Technology's latest funding round was a Convertible Note for $3,000M on June 11, 2021.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
|---|---|---|---|---|---|---|
6/11/2021 | Convertible Note | $3,000M | 2 | |||
3/31/2021 | Series A - II | |||||
3/1/2021 | Series A | |||||
8/25/2020 | Acquired |
Date | 6/11/2021 | 3/31/2021 | 3/1/2021 | 8/25/2020 |
|---|---|---|---|---|
Round | Convertible Note | Series A - II | Series A | Acquired |
Amount | $3,000M | |||
Investors | ||||
Valuation | ||||
Revenue | ||||
Sources | 2 |
This profile has not been claimed.
You're more than your latest funding, tell our customers your company's story.
Orange Heart Optimal Technology Investors
2 Investors
Orange Heart Optimal Technology has 2 investors. Didi Chuxing invested in Orange Heart Optimal Technology's Convertible Note funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
|---|---|---|---|---|---|---|
8/25/2020 | 6/11/2021 | 2 Acquired, Convertible Note (2021) | Corporation | China | ||
Venture Capital | New York |
First funding | 8/25/2020 | |
|---|---|---|
Last Funding | 6/11/2021 | |
Investor | ||
Rounds | 2 Acquired, Convertible Note (2021) | |
Board Seats | ||
Type | Corporation | Venture Capital |
Location | China | New York |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.